Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection

Core Insights - Alzheimer's disease is a significant public health challenge in Hong Kong, with projections indicating that by 2036, the number of individuals with dementia will reach 280,000, with Alzheimer's accounting for approximately 65% of these cases [1][2] - A recent breakthrough in Alzheimer's treatment has been achieved through the collaboration between a leading Hong Kong university and eefit, utilizing far infrared technology to address dual-pathology mechanisms in the disease [3][5] Research and Development - The research team conducted a 28-day study using a TgCRND8 transgenic mouse model, demonstrating that eefit far infrared technology can simultaneously reduce β-amyloid deposition and tau protein hyperphosphorylation [4][5] - The study revealed significant improvements in cognitive function and memory in FIR-treated mice, alongside reductions in Aβ deposition and tau protein hyperphosphorylation [7][8] Industrial Application - eefit is focused on transforming scientific research into industrial applications, having established a global R&D system and partnerships with notable institutions to enhance its capabilities [9][10] - The company has developed a comprehensive health management system targeting the middle-aged and elderly population, addressing disease prevention and daily health management needs [17] Social Responsibility and Market Response - eefit launched the "eBrain Movement" in 2024, providing brain health services to 212,000 individuals, with positive feedback on improvements in neurodegenerative symptoms and sleep quality [11][13] - The company emphasizes its commitment to ongoing investment in technological R&D to drive advancements in health technology [17]